ChiragAcharyaMD

PubMed

• 20 citations
  Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis
  Prakrati C Acharya, Charat Thongprayoon, Panupong Hansrivijit, Swetha R Kanduri, Karthik Kovvuru, Juan Medaura, Pradeep Vaitla, D. G. Anton, Poemlarp Mekraksakit, Patt...> ;Diseases. 2021 May 25
• 57 citations
  APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
  Yu-Tzu Tai, Liang Lin, Lijie Xing, Shih-Feng Cho, Tengteng Yu, Kenneth Wen, Phillip A Hsieh, John Dulos, Andrea van Elsas, Nikhil C. Munshi, Paul G. Richardson, Kennet...> ;Leukemia. 2019 Feb 1
• 174 citations
  Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.
  Xiaoyan Feng, Li Zhang, Gang An, Kenneth Wen, Lugui Qiu, Nikhil C. Munshi, Yu-Tzu Tai, Kenneth C. Anderson> ;Clinical Cancer Research. 2017 Aug 1
• 16 citations
  Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.
  , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2016 Dec 15
• 59 citations
  Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myel...
  , , , , , , , , , , , , , , , , , > ;Oncotarget. 2017 Mar 21
• 127 citations
  Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
  Gang An, Xiaoyan Feng, Kenneth Wen, Mike Zhong, Li Zhang, Nikhil C. Munshi, Lugui Qiu, Yu-Tzu Tai, Kenneth C. Anderson> ;Blood. 2016 Sep 22
• 218 citations
  APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.
  Yu-Tzu Tai, Gang An, Michele Moschetta, Mike Y Zhong, Xiaoyan Feng, Michele Cea, Antonia Cagnetta, Kenneth Wen, Hans van Eenennaam, Andrea van Elsas, Lugui Qiu, Paul G...> ;Blood. 2016 Jun 23
• 79 citations
  Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells.
  , , , , , , , , , , , , , , , , , , , , > ;Blood. 2016 Mar 3
• SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.
  Jiang H, Acharya C, An G, Zhong M, Feng X, Wang L, Dasilva N, Song Z, Yang G, Adrian F, Qiu L, Richardson P, Munshi NC, Tai Y, Anderson KC> ;Leukemia. 2016-02-01
• 13 citations
  Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH
  , , , , , , , , , , , , , , , , , > ;Oncotarget. 2015 Sep 22
• 30 citations
  APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
  , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2015 May 11
• 74 citations
  The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence In Situ Hybridization in Multiple Myeloma
  , , , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2015 May 1
• 10 citations
  Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment
  , , , , , , , , , , , , , , , , , , > ;Experimental Hematology. 2015 Mar 1
• Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
  An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z, Hao M, Feng X, Jin F, Zou D, Qi J, Zhao Y, Tai Y, Wang J, Qiu L> ;Ann. Hematol.. 2015-02-01
• 28 citations
  Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.
  Antonia Cagnetta, Sophia Adamia, Franco Patrone, Maurizio Miglino, Alessio Nencioni, Marco Gobbi, Michele Cea> ;Leukemia Research. 2014 Jun 1
• 328 citations
  Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.
  Yu-Tzu Tai, Patrick A. Mayes, Chirag Acharya, Mike Y Zhong, Michele Cea, Antonia Cagnetta, Jenny L Craigen, John Yates, Louise Gliddon, William E. Fieles, Bao Hoang, J...> ;Blood. 2014 May 15
• CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.
  Tai Y, Landesman Y, Acharya C, Calle Y, Zhong MY, Cea M, Tannenbaum D, Cagnetta A, Reagan M, Munshi AA, Senapedis W, Saint-Martin JR, Kashyap T, Shacham S, Kauffman M,...> ;Leukemia. 2014-01-01
• Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity.
  Cagnetta A, Cea M, Calimeri T, Acharya C, Fulciniti M, Tai Y, Hideshima T, Chauhan D, Zhong MY, Patrone F, Nencioni A, Gobbi M, Richardson P, Munshi N, Anderson KC> ;Blood. 2013-08-15
• Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
  Tai Y, Chang BY, Kong S, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao J, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elias L...> ;Blood. 2012-08-30
• Join now to see all